Khiron Life Sciences Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Khiron Life Sciences Corp. generated cash of -$20,865,000, which is more than the previous year. Cash used in financing activities reached the amount of $10,895,000 last year. Net change in cash is therefore -$12,726,000.
Cash Flow
| 2019 | -30.07M | -31.97M | 56.99M |
|---|---|---|---|
| 2020 | -24.53M | 24.86M | 12.17M |
| 2021 | -20.86M | -2.08M | 10.89M |
KHRN.V Cash Flow Statement (2019 – 2021)
| 2021 | 2020 | 2019 | |
|---|---|---|---|
Cash at beginning of period | 21.64M | 9.34M | 15.01M |
Operating activities | |||
Net income | -33.12M | -24.03M | -36.37M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | -1.11M | -1.16M | -938.53K |
Stock-based compensation expense | 2.32M | 5.71M | 9.37M |
| Deferred income tax benefit | 2.32M | 5.71M | 9.37M |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 2.30M | 605.75K | -1.38M |
Inventories | -1.44M | -2.06M | -700.44K |
Accounts payable | -2.83M | -1.86M | 848.90K |
Cash generated by operating activities | -20.86M | -24.53M | -30.07M |
Investing activities | |||
Purchases Of Investments | 0 | 0 | -23.05M |
Investments In Property Plant And Equipment | -1.74M | -2.69M | -6.09M |
Acquisitions Net | -342K | 0 | -2.83M |
Cash generated by investing activities | -2.08M | 24.86M | -31.97M |
Financing activities | |||
Common Stock Issued | 11.00M | 12.93M | 58.26M |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | -212.38K | 0 |
Repayments of term debt | -107K | -555.19K | 0 |
Cash used in financing activities | 10.89M | 12.17M | 56.99M |
Net Change In Cash | -12.72M | 12.30M | -5.66M |
Cash at end of period | 8.92M | 21.64M | 9.34M |